Laboratory Corporation of America Holdings (LabCorp)
1447 York Court
Burlington
North Carolina
27215
United States
Tel: 336-584-5171 or 800-331-2843
Website: http://www.labcorp.com/
411 articles about Laboratory Corporation of America Holdings (LabCorp)
-
Conversion Right Triggered For LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
1/3/2017
-
LabCorp Announces 2016 Third Quarter Results And Updates 2016 Guidance
10/26/2016
-
LabCorp Is First US Laboratory To Offer Molecular Testing With New Fully Automated Cobas 8800 System From Roche
10/24/2016
-
LabCorp Subsidiary Sequenom Announces Expiration Of And Final Tender Results For Tender Offers For 5% Convertible Senior Notes Due 2017 And 5% Convertible Senior Exchange Notes Due 2018
10/18/2016
-
LabCorp Subsidiary Sequenom Announces Early Tender Results For Tender Offers And Successful Completion Of Consent Solicitations For 5% Convertible Senior Notes Due 2017 And 5% Convertible Senior Exchange Notes Due 2018
9/30/2016
-
LabCorp Names Biopharma Vet CEO of Covance Drug Development
9/21/2016
-
LabCorp Subsidiary Sequenom Announces Tender Offers And Consent Solicitations for 5% Convertible Senior Notes Due 2017 And 5% Convertible Senior Exchange Notes Due 2018
9/19/2016
-
LabCorp Successfully Completes Acquisition Of Sequenom
9/7/2016
-
LabCorp Is Scheduled To Present At The Morgan Stanley Global Healthcare Conference
9/6/2016
-
LabCorp’s Acquisition Of Sequenom Clears Antitrust Review
8/23/2016
-
LabCorp Commences Cash Tender Offer For All Outstanding Shares Of Sequenom
8/9/2016
-
LabCorp Announces The Availability Of The CDC Zika MAC-ELISA Test
8/2/2016
-
After $371 Million Merger, What's Next for LabCorp and Sequenom?
7/29/2016
-
LabCorp Gobbles Up SoCal's Sequenom for $302 Million
7/27/2016
-
LabCorp Announces Agreement To Acquire Sequenom
7/27/2016
-
LabCorp Announces Agreement To Acquire Sequenom
7/27/2016
-
Transgenomic, Inc. Licenses Commercial Rights To Its Long QT Syndrome DNA Testing Portfolio To LabCorp
7/20/2016
-
Conversion Right Triggered For LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
7/1/2016
-
LabCorp Announces Launch Of New Companion Diagnostic For Non-Small Cell Lung Cancer
6/27/2016
-
LabCorp Is Scheduled To Present At The 36th Annual William Blair Growth Stock Conference
6/9/2016